Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Rating) was the recipient of a significant drop in short interest in April. As of April 30th, there was short interest totalling 148,700 shares, a drop of 21.9% from the April 15th total of 190,400 shares. Based on an average daily trading volume, of 708,000 shares, the short-interest ratio […]
Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Rating) was the target of a large decrease in short interest in March. As of March 31st, there was short interest totalling 144,600 shares, a decrease of 45.1% from the March 15th total of 263,500 shares. Based on an average daily trading volume, of 760,200 shares, the days-to-cover ratio […]
Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Rating) was the recipient of a significant decline in short interest in March. As of March 31st, there was short interest totalling 144,600 shares, a decline of 45.1% from the March 15th total of 263,500 shares. Based on an average daily volume of 760,200 shares, the short-interest ratio is […]
Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Rating) was the target of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 263,500 shares, an increase of 449.0% from the February 28th total of 48,000 shares. Based on an average daily trading volume, of 2,740,000 shares, […]
Vivos Therapeutics (NASDAQ:VVOS – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Friday, Zacks.com reports. According to Zacks, “Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered […]